U.S. flag

An official website of the United States government

NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 8, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000807329.4

Allele description [Variation Report for NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter)]

NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter)

Gene:
RPS6KA3:ribosomal protein S6 kinase A3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp22.12
Genomic location:
Preferred name:
NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter)
HGVS:
  • NC_000023.11:g.20187875G>A
  • NG_007488.1:g.83758C>T
  • NM_004586.3:c.727C>TMANE SELECT
  • NP_004577.1:p.Arg243Ter
  • NC_000023.10:g.20205993G>A
  • NM_004586.2:c.727C>T
Protein change:
R243*
Links:
dbSNP: rs1603425345
NCBI 1000 Genomes Browser:
rs1603425345
Molecular consequence:
  • NM_004586.3:c.727C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Coffin-Lowry syndrome (CLS)
Synonyms:
Mental retardation with osteocartilaginous abnormalities; Coffin syndrome; COFFIN-LOWRY SYNDROME, MILD
Identifiers:
MONDO: MONDO:0010561; MedGen: C0265252; Orphanet: 192; OMIM: 303600
Name:
Intellectual disability, X-linked 19 (XLID19)
Synonyms:
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19
Identifiers:
MONDO: MONDO:0010447; MedGen: C0796225; Orphanet: 777; OMIM: 300844

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000947376Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 8, 2021)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome.

Delaunoy J, Abidi F, Zeniou M, Jacquot S, Merienne K, Pannetier S, Schmitt M, Schwartz C, Hanauer A.

Hum Mutat. 2001 Feb;17(2):103-16.

PubMed [citation]
PMID:
11180593

Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.

Jacquot S, Merienne K, De Cesare D, Pannetier S, Mandel JL, Sassone-Corsi P, Hanauer A.

Am J Hum Genet. 1998 Dec;63(6):1631-40.

PubMed [citation]
PMID:
9837815
PMCID:
PMC1377634
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV000947376.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individuals with Coffin-Lowry syndrome (PMID: 11180593). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg243*) in the RPS6KA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPS6KA3 are known to be pathogenic (PMID: 9837815, 19888300).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024